Kijak GH - Search Results

1

Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.

Kijak GH, Pampuro SE, Avila MM, Zala C, Cahn P, Wainberg MA, Salomón H. Kijak GH, et al. Antivir Ther. 2001 Mar;6(1):71-7. Antivir Ther. 2001. PMID: 11417764

2

A highly prevalent polymorphism at codon 72 of HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LiPA genotyping test.

Kijak GH, Carobene MG, Salomón H. Kijak GH, et al. J Virol Methods. 2001 May;94(1-2):87-95. doi: 10.1016/s0166-0934(01)00276-2. J Virol Methods. 2001. PMID: 11337043

3

Mother-to-child transmission of drug-resistant HIV.

Kijak GH, Avila MM, Salomón H. Kijak GH, et al. Drug Resist Updat. 2001 Feb;4(1):29-37. doi: 10.1054/drup.2001.0182. Drug Resist Updat. 2001. PMID: 11512150 Review.

4

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.

Kijak GH, Rubio AE, Quarleri JF, Salomón H. Kijak GH, et al. AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1415-21. doi: 10.1089/088922201753197088. AIDS Res Hum Retroviruses. 2001. PMID: 11679154

5

[Distribution of subtypes and recombinant of HIV. Situation in Argentina].

Cómez Carrillo M, Salomón H, Pando MA, Kijak G, Avila MM. Cómez Carrillo M, et al. Medicina (B Aires). 2001;61(6):881-9. Medicina (B Aires). 2001. PMID: 11808433 Review. Spanish.

6

Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.

Zala C, Salomon H, Ochoa C, Kijak G, Federico A, Perez H, Montaner JS, Cahn P. Zala C, et al. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):368-73. doi: 10.1097/00126334-200204010-00007. J Acquir Immune Defic Syndr. 2002. PMID: 11917241 Clinical Trial.

7

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.

Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H. Kijak GH, et al. J Virol. 2002 Jul;76(14):7000-9. doi: 10.1128/jvi.76.14.7000-7009.2002. J Virol. 2002. PMID: 12072500 Free PMC article.

8

Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.

Kijak GH, Rubio AE, Pampuro SE, Zala C, Cahn P, Galli R, Montaner JS, Salomón H. Kijak GH, et al. HIV Med. 2003 Jan;4(1):72-8. doi: 10.1046/j.1468-1293.2003.00131.x. HIV Med. 2003. PMID: 12534963 Free article.

9

Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples.

Carobene MG, Rubio AE, Carrillo MG, Maligne GE, Kijak GH, Quarleri JF, Salomón H. Carobene MG, et al. Among authors: kijak gh. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):207-9. doi: 10.1097/00126334-200402010-00018. J Acquir Immune Defic Syndr. 2004. PMID: 14722457 No abstract available.

10

Transmitted, pre-treatment and acquired antiretroviral drug resistance among men who have sex with men and transgender women living with HIV in Nigeria.

Crowell TA, Kijak GH, Sanders-Buell E, O'Sullivan AM, Kokogho A, Parker ZF, Lawlor J, Polyak CS, Adebajo S, Nowak RG, Baral SD, Robb ML, Charurat ME, Ake JA, Ndembi N, Tovanabutra S; TRUST/RV368 Study Group. Crowell TA, et al. Among authors: kijak gh. Antivir Ther. 2019;24(8):595-601. doi: 10.3851/IMP3342. Antivir Ther. 2019. PMID: 32125280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters